View More Recent Stories

Oct 14, 2024 02:18PM TD Cowen Reiterates Buy Rating on Spyre (SYRE)
Oct 14, 2024 08:01AM Spyre Therapeutics (SYRE) Announces Expected Acceleration of SPY003 Clinical Timelines
Oct 1, 2024 08:02AM Spyre Therapeutics (SYRE) Appoints Sheldon Sloan as Chief Medical Officer
Sep 25, 2024 06:41AM BTIG Reiterates Buy Rating on Spyre (SYRE)
Sep 20, 2024 04:09PM Spyre Therapeutics (SYRE) Files for 46.33M Share Offering by Selling Stockholders
Sep 6, 2024 04:13PM Spyre Therapeutics (SYRE) Files Mixed Shelf
Aug 8, 2024 04:06AM Spyre Therapeutics, Inc. (SYRE) Tops Q2 EPS by 9c
Jul 18, 2024 08:06AM NewAmsterdam Pharma (NAMS) Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
Jul 16, 2024 07:02AM Evercore ISI Starts Spyre (SYRE) at Outperform
View More Recent Stories